Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-027394
Filing Date
2018-04-27
Accepted
2018-04-27 08:34:56
Documents
5
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3087_3defa14a.htm DEFA14A 32489
2 GRAPHIC g30873bci001.gif GRAPHIC 37687
3 GRAPHIC g30873bci002.gif GRAPHIC 78387
4 GRAPHIC g30873bci003.gif GRAPHIC 10598
5 GRAPHIC g30873bci004.gif GRAPHIC 1688
  Complete submission text file 0001104659-18-027394.txt   210699
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37687 | Film No.: 18781139
SIC: 2836 Biological Products, (No Diagnostic Substances)